RecruitingNot ApplicableNCT07422792

Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients

Anabolic Response To Protein And Assessment Of Metabolic Phenotype In Patients With Home Parenteral Nutrition And Chronic Intestinal Failure


Sponsor

Institute of Oncology Ljubljana

Enrollment

40 participants

Start Date

Apr 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to gain insight into the actual protein requirements of patients with chronic intestinal failure (CIF) receiving home parenteral nutrition, which could improve clinical management of these patients. Based on collected data on protein kinetics, the study aims to further refine and personalize nutritional mixtures in patients with CIF. Additional aims include assessment of short-chain fatty acid metabolism and evaluation of gut microbiota function in patients with CIF.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- Patients with chronic intestinal failure (CIF) receiving home parenteral nutrition.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIntravenous Amino Acids

Intravenous amino acid administration to assess anabolic response and protein kinetics in patients with chronic intestinal failure receiving home parenteral nutrition


Locations(1)

Institute of Oncology Ljubljana

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07422792